296 related articles for article (PubMed ID: 26503153)
1. Functionalized magnetic nanoparticles for biomedical applications.
Gudovan D; Balaure PC; Mihăiescu DE; Fudulu A; Purcăreanu B; Radu M
Curr Pharm Des; 2015; 21(42):6038-54. PubMed ID: 26503153
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanoparticles based cancer therapy: current status and applications.
Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
Vallabani NVS; Singh S; Karakoti AS
Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
[TBL] [Abstract][Full Text] [Related]
4. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
Mosayebi J; Kiyasatfar M; Laurent S
Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
[TBL] [Abstract][Full Text] [Related]
6. Voyage of theranostic liposomes for imaging and therapy.
Sachin M; Sachin D; Dinesh S
J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide nanoparticles - In vivo/in vitro biomedical applications and in silico studies.
Nedyalkova M; Donkova B; Romanova J; Tzvetkov G; Madurga S; Simeonov V
Adv Colloid Interface Sci; 2017 Nov; 249():192-212. PubMed ID: 28499604
[TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.
Nosrati H; Salehiabar M; Kheiri Manjili H; Davaran S; Danafar H
Drug Dev Ind Pharm; 2018 Oct; 44(10):1668-1678. PubMed ID: 29848101
[TBL] [Abstract][Full Text] [Related]
9. Magnetic iron oxide nanoparticles as drug carriers: preparation, conjugation and delivery.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):929-952. PubMed ID: 29546817
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles.
Felton C; Karmakar A; Gartia Y; Ramidi P; Biris AS; Ghosh A
Drug Metab Rev; 2014 May; 46(2):142-54. PubMed ID: 24754519
[TBL] [Abstract][Full Text] [Related]
11. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
Amiri M; Salavati-Niasari M; Akbari A
Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
[TBL] [Abstract][Full Text] [Related]
12. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
13. Multivalent nanoparticles for personalized theranostics based on tumor receptor distribution behavior.
Zhang Y; Cheng M; Cao J; Zhang Y; Yuan Z; Wu Q; Wang W
Nanoscale; 2019 Mar; 11(11):5005-5013. PubMed ID: 30839969
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
Li L; Liu H
Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
[No Abstract] [Full Text] [Related]
15. Engineered Theranostic Magnetic Nanostructures: Role of Composition and Surface Coating on Magnetic Resonance Imaging Contrast and Thermal Activation.
Nandwana V; Ryoo SR; Kanthala S; De M; Chou SS; Prasad PV; Dravid VP
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6953-61. PubMed ID: 26936392
[TBL] [Abstract][Full Text] [Related]
16. Advances in Magnetic Nanoparticles for Biomedical Applications.
Cardoso VF; Francesko A; Ribeiro C; Bañobre-López M; Martins P; Lanceros-Mendez S
Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29280314
[TBL] [Abstract][Full Text] [Related]
17. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
El-Boubbou K
Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
[TBL] [Abstract][Full Text] [Related]
18. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches of magnetic nanoparticles for the central nervous system.
Dilnawaz F; Sahoo SK
Drug Discov Today; 2015 Oct; 20(10):1256-64. PubMed ID: 26103617
[TBL] [Abstract][Full Text] [Related]
20. Magnetic nanoparticles in nanomedicine: a review of recent advances.
Wu K; Su D; Liu J; Saha R; Wang JP
Nanotechnology; 2019 Dec; 30(50):502003. PubMed ID: 31491782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
